Entering text into the input field will update the search result below

FDA gives positive feedback on Tetra Bio's ARDS-003 application in COVID-19

  • The FDA has favorably reviewed the preclinical data package and clinical development plan of Tetra Bio-Pharma's (OTCQB:TBPMF) ARDS-003 to treat COVID-19.
  • The Agency agreed with the animal toxicology and safety data to ensure that ARDS-003 is safe for human use, and approved

Recommended For You

More Trending News

Related Stocks

SymbolLast Price% Chg
TBPMQ
--
TBP:CA
--